Clinical trial / 2019
Metformin attenuated exercise-induced gains in insulin sensitivity, VO2 max, and skeletal muscle mitochondrial respiration in older adults.
Older adults underwent 12 weeks of aerobic exercise training (AET) while randomized double-blind to placebo (n = 26) or metformin (n = 27). Independent of treatment, AET decreased fat mass, HbA1c, fasting plasma insulin, 24-hr ambulant mean glucose, and glycemic variability. However, metformin attenuated improvements in whole-body insulin sensitivity and VO2 max, and abrogated increases in skeletal muscle mitochondrial respiration. Mitochondrial protein synthesis rates were not different between treatments.
- Study type
- Double-blind randomized controlled trial
- Who was studied
- 53 older adults (62 ± 1 years; placebo n = 26, metformin n = 27)
- What was measured
- Insulin sensitivity, VO2 max, mitochondrial respiration, and protein synthesis
THE PAPER
Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults.
Konopka AR, Laurin JL, Schoenberg HM, Reid JJ, Castor WM, Wolff CA, Musci RV, Safairad OD, Linden MA, Biela LM, Bailey SM, Hamilton KL, Miller BF. Aging Cell, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.